Tim David Wins Fourth Straight for Hobart Hurricanes
In a thrilling contest at Hobart on Sunday...
Radiant Biotherapeutics Secures $35M to Advance Therapeutic Platform for Life-threatening Diseases
Radiant Biotherapeutics Secures $35M to Advance Therapeutic Platform for Life-threatening DiseasesRadiant Biotherapeutics, a Toronto-based pre-clinical biotechnology startup developing an advanced antibody platform to offer life-changing therapies for patients with life-threatening diseases, has secured $35 million in Series A funding round to fuel growth and advance its platform for clinics. Led by Arthur Fratamico and Jo Hulme, the company’s platform offers diverse biologics to help fight difficult-to-treat illnesses such as infectious diseases, auto-immune, and cancer, allowing healthcare professionals to unlock cures for patients.
Please login to comment on this Post